518O Overall survival results from ARIEL4: A phase III study assessing rucaparib vs chemotherapy in patients with advanced, relapsed ovarian carcinoma and a deleterious BRCA1/2 mutation
| Autor: | Oza, A.M., Lisyanskaya, A.S., Fedenko, A.A., de Melo, A.C., Shparik, Y., Bondarenko, I., Colombo, N., Lorusso, D., Cibula, D., Póka, R.L., Oaknin, A., Safra, T., Maćkowiak-Matejczyk, B., Ma, L., Thomas, D., Lin, K.K., McLachlan, K., Goble, S., Kristeleit, R. |
|---|---|
| Zdroj: | In Annals of Oncology September 2022 33 Supplement 7:S780-S780 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|